Investor Ideas #Potcasts,
#Cannabis News and #Stocks on the Move; Episode 427 (TSXV: $NUMI.V) (CSE: $IPOT.C)
(TSXV: $RTI.V) (OTC: $ERBB)
Delta, Kelowna, BC, June 11, 2020
(Investorideas.com Newswire) www.Investorideas.com, a global news source
covering leading sectors including marijuana and hemp stocks and its potcast
site, www.potcasts.ca release today’s podcast edition of cannabis
news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Read
this in full at https://www.investorideas.com/news/2020/cannabis-potcasts/06111NUMI-IPOT-RTI-ERBB.asp
Today’s podcast overview/transcript:
Good afternoon and welcome to another episode of
Investorideas.com "Potcast" featuring cannabis news, stocks to watch
as well as insights from thought leaders and experts.
In today’s podcast we look at a few public and
private company announcements.
Numinus Wellness Inc. (TSX-V:NUMI) (OTC:
LKYSD) announced receiving Health Canada approval to amend the
Company's existing Licence under the Controlled Drug and Substances Act to
allow Numinus researchers to conduct research to standardize the extraction of
psilocybin from mushrooms. The amendment means Numinus is the first publicly
traded company in Canada to be granted a licence by Health Canada to conduct
research of this kind.
With this regulatory approval, Numinus is able to
proceed with the production of naturally sourced, sustainable psilocybin for
research purposes that will support the emerging field of psychedelic assisted
therapy and research, at lower costs to currently produced synthetic
psilocybin. The licence also allows Numinus to develop and licence its own
exclusive IP for further product development in partnership with leading
research organizations — something the research community has been seeking to
secure. The work will be eligible for the Government of Canada's Scientific
Research and Experimental Development (SR&ED) tax incentive program and
will lay a foundation for grant applications.
"We are proud to be at the forefront of a
new therapeutic category by advancing evidence-based science focused on
wellness and personal connection at its core," says Numinus CEO Payton
Nyquvest. "Numinus is the only publicly traded company in Canada approved
to develop a consistent psilocybin extraction method from naturally-produced
mushrooms at a time when alternative therapeutic methods are increasingly being
investigated and demand from clinical research is growing."
Working from the 7,000 square-foot Numinus
Bioscience research facility and laboratory, senior research scientists Dr.
Kristina Grotzinger and Dr. Bernd Keller will focus on developing a proprietary
extraction method from mushrooms to allow for consistent dosing and application
of naturally produced psilocybin. Once a proprietary method has been developed,
the Company intends to explore supply agreements with leading research
organizations to make use of the product in their clinical and therapeutic
work.
Researchers at Johns Hopkins University, the
Multidisciplinary Association for Psychedelic Substances (MAPS) and other
leading researchers have published studies showing the benefits of psilocybin
in treating Post-Traumatic Stress Disorder (PTSD) and other mental health
issues. Further, the US Food and Drug Administration has granted breakthrough
therapy status for psilocybin for the treatment of PTSD — illustrating the
growing demand for therapeutic access to psilocybin.
"In most cases, the creation of synthetic
compounds are less pure than those found in nature, which is the case with
psilocybin," says Dr. Grotzinger. "There is risk of contamination
from solvents, gases and other chemicals, which makes them less safe to work
with and requires added safety and processing expense. By working directly with
the mushroom in its natural state, these risks are reduced, as is the cost to
extract the psilocybin." Grotzinger added that standardized plant or
fungi extracts are accepted by European standards and are a common dosage form
in Europe.
Isracann Biosciences Inc. (CSE:
IPOT) (OTC:
ISCNF), an Israel-based company focused on
becoming a premier low cost, high quality cannabis producer announced its support of recent news reports signaling a
move towards increased legalization of cannabis use for both medical and
recreational users.
Last week, the Israeli Police Minister backed the
easing of enforcement of existing laws, which was followed by a joint statement
by the Prime Minister and Defense Minister outlining their intent to advance
legislation “to resolve the issue of decriminalization and legalization”
ostensibly referring to recreational cannabis use.
The statement further noted a determination to
advance medical cannabis reforms in order to make it easier for patients to
gain access to treatments and for growers to receive permits.
The report indicated agreement on an outline for
reform that includes; cannabis to be permitted only for those over the age of
21, excludes those in security-related occupations; prohibits driving under the
influence of cannabis and went on to note sales will only be permitted through
authorized outlets, and there will be restrictions on cannabis advertising.
Many government and public figures are echoing support for responsible national
reform initiatives.
"We are incredibly pleased by the recent
news and are highly supportive of the initial proposals moving towards medical
and recreational reform," said Darryl Jones, Chief Executive Officer of
Isracann. “We look forward to building on this legislative framework as we
continue to execute our strategic plans in the region.”
HelloMD,
the leading virtual healthcare platform for medical cannabis in Canada, announced that it is offering a new Senior Care service
that gives 65+ patient community across Canada simpler access to medical
cannabis support to help keep them informed and cared for during COVID-19.
HelloMD is the exclusive telehealth partner of
Medical Cannabis by Shoppers, Shoppers Drug Mart's online platform for the sale
of medical cannabis. Through the partnership HelloMD provides patients in
Canada with convenient access to practitioner-led advice about medical
cannabis.
HelloMD's new Senior Care service offers
low-tech, high-touch access to educational content and licensed practitioners,
all from the safety and comfort of their homes. The service offers seniors a
simple 3-step process that connects them with an experienced practitioner and,
if authorized, with a Medical Cannabis by Shoppers virtual pharmacists to
assist with product prescriptions and fulfillment.
According to Statscan National Cannabis Survey
seniors are the fastest growing age group utilizing cannabis. With more than a
quarter of 65+ cannabis users new to cannabis, the need for education and
services that cater specifically to them is clear.
"It's no surprise that we see so many more
seniors curious about using medical cannabis," said Wendy Wiley, RN, MN,
NP. "From my experience, this is a group more likely to present with
symptoms resistant to first and second line treatment options, or to be
experiencing intolerable side effects from other treatments. But cannabis is
not a silver bullet; seniors need access to sound advice on how to use medical
cannabis safely, in the context of their conditions and other currently
prescribed medications," added Wiley.
The new Senior Care service also includes
regularly updated educational content tailored around the needs of those
seniors using or seeking advice on the use of medical cannabis.
"Since the start of 2020, we have seen more
than 250% growth in demand from 65+ patients seeking practitioner advice on
medical cannabis," said Larry Lisser Senior Vice President of HelloMD.
With the ongoing associated risks of COVID-19, seniors need access to safe and
trusted sources for their health care needs; yet virtual health is new and
sometimes can feel cumbersome for this community. That's why we have
re-engineered our processes and platform so that seniors can enjoy the safety
and convenience of virtual health services, but without the frustration that
technology can sometimes present," Lisser added.
"We want seniors to have trusted access to
the widest variety of medical cannabis products available in Canada today,
" said Ken Weisbrod, Vice President of Business Development, Shoppers Drug
Mart. "Be it by way of simpler access to licensed practitioners, or our
pricing programs designed to help seniors better afford their medical cannabis,
we want to ensure that seniors have the support they need to streamline this
aspect of their healthcare journey.".
Radient Technologies Inc. (TSX-V:
RTI) (OTCQX:
RDDTF), a global commercial manufacturer of high
quality cannabinoid-based ingredients, formulations and products, announced that its recently launched bioU branded products
are now available through Medical Cannabis by Shoppers, a subsidiary of
Shoppers Drug Mart Inc.
The bioU brand was created exclusively for
Medical Cannabis by Shoppers and is now available across Canada. bioU products
have been scientifically designed by Radient to provide a high quality,
consistent, broad spectrum oil formulations to medical users. The first series
of products to launch is the USpray line of extracts which come in a
convenient, precise dosage oral spray format. A CBD dominate (1:20 ratio of
THC:CBD) and balanced formulation (1:1 ratio of THC:CBD) are now available,
with a THC dominate formula (30:1 ratio of THC:CBD) expected shortly.
The Company has also received the approval from
the TSX Venture Exchange for a series of shares for debt agreements with
various of its creditors, which was previously announced in a press release
dated May 8, 2020 under the terms and conditions noted in the press release.
American Green (OTC:
ERBB) announced today that the strategic shifts that began in
2019 are now paying dividends in every division. According to David
Gwyther, president of American Green, “During 2019 and early 2020, the company
had to make changes in every division to accommodate the changing
marketplace. I’m pleased to report that those changes resulted in each
division’s revenue improvements compared to the same periods over the previous
year.”
VP of CBD Worldwide Sales, Kevin Davis, said,
“The key to the success of the American Green Online CBD Store is a combination
of Top-Shelf Customer Service, The Integration of Technology, Competitive
Pricing, Easy Payment Options, and Product Selection. Since our online CBD
Store first opened 3 years ago, our growth has been primarily driven by our
extreme sensitivity to customer feedback -- by listening very, very
carefully. Whether that means incorporating a capability to quickly
respond to customer questions via email or phone, and making damn sure our
customers know that they’re getting the best CBD available and are 100%
satisfied, even if that means staying on the phone with them until they get all
the information they need.”
“Every customer is unique to us and when our
store employees show them the courtesy of our unrushed time -- whether by email
or phone, it is the only way we know of guaranteeing that our loyal base
returns to us. Other companies talk about achieving goals like these, but we,
at the American Green CBD Store live this ‘customer-driven lifestyle’ every
day,” concludes Kevin.
According to Bryan Croteau, American Green’s VP
of Grow Operations, “As the world comes out of quarantine and things get back
to the ‘new normal,’ American Green’s ‘Sweet Virginia’ is turning out some of
the highest grade cannabis found in Arizona and is hard at work upgrading its
production facility while producing American Green’s newest cannabis product
line. Our Sweet Virginia facility is proud to announce that the first wave of
American Green Full Spectrum Solventless Concentrate products have hit the
retail shelves at the Kind Meds licensed dispensary located at 2152 South
Vineyard, Suite 120, Bldg 7, Mesa AZ 85210.”
American Green’s Sweet Virginia grow operation is
most proud of its Ice-water-extracted Bubble Hash which is also known as “Full
Melt,” because it leaves no residue when compared to standard hash which has
been made the same way for hundreds of years. According to Mr. Croteau, “Our
special process manually removes the THC trichomes using nothing but ice and
water and produces one of the safest and most natural concentrates available
anywhere. If you are a current medical patient in the State of Arizona, we
highly recommend a trip to Kind Meds for an opportunity to taste our best grown
flowers in the form of concentrate! I would call first before making the
trip to ensure that the American Green Bubble Hash has not been sold out, as we
anticipate high demand for this premium product.”
The Sweet Virginia Grow has also recently added
10% of canopy space as an additional flower room thus enabling the operation to
increase its revenues by about 10% per annum. This new space will allow for
production of an extra 240 plants every 8 weeks. We are also constantly
streamlining tasks to be as efficient as possible, which has allowed us to cut
our current payroll costs by about 12% when compared to last quarter.
The American Green Machine (AGM) Division has
been working to add new features to its Smart Vending Kiosk such as lower risk
touchless shopping which will allow vending customers to utilize a QR Code and
be able to use their own cell phone to interact with our AGM Kiosk.
Employing “Covid-19 Sensitivity,” customers will no longer need to touch the
machine to view the AGM’s products with the goal of allowing customers to
complete their entire transaction on their smartphone. This new feature
has been designed to be “backwards compatible” thus enabling the feature to be
available for existing machines already in service and is now ready to
rollout. According to AGM Division VP, Lindel Creed,
“We are very excited with the progress of the AGM
kiosk as sales increase this year and more customers become convinced that the
AGM is the best verified vending system on the market.”
Investor ideas reminds all listeners to
read our disclaimers and disclosures on the Investorideas.com
website and this podcast is not an endorsement to buy products or services or
securities. Investors are reminded all investment involves risk and possible
loss of investment
Investorideas.com podcasts are also available on
iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube
via Spreaker, iHeartradio and Tunein.
Potcasts is now
a certified word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About
Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news
source publishing third party news, research and original financial content.
Learn about investing in stocks and sector trends with our news alerts,
articles, podcasts and videos, looking at cannabis, crypto, AI and
IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s
original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas
Potcasts Cannabis News and Stocks on the Move
podcast and column, Cleantech and
Climate Change , Exploring Mining the AI Eye .
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and
equity research as well as creates original content, including video,
interviews and articles. Original content created by investorideas is protected
by copyright laws other than syndication rights. Our site does not make
recommendations for purchases or sale of stocks, services or products. Nothing
on our sites should be construed as an offer or solicitation to buy or sell
products or securities. All investing involves risk and possible losses. This
site is currently compensated for news publication and distribution, social
media and marketing, content creation and more. Disclosure is posted for each
compensated news release, content published /created if required but otherwise
the news was not compensated for and was published for the sole interest of our
readers and followers. Contact management and IR of each company directly
regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other
news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country.
Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where
permissible by law. Our site does not possess, distribute, or sell cannabis
products.
Contact Investorideas.com
800 665 0411
No comments:
Post a Comment